New InstaDataNewsOur live magazine on AI, Agentic AI & Robotics — updated daily Explore the Magazine ↗
Skip to content
General Blogs

NMC Advertising Guidelines: An AI Checklist for Clinics

Dr. Subhabaha Pal (Guest Author)
7 min read
NMC Advertising Guidelines: An AI Checklist for Clinics

On 6 October 2026, the National Medical Commission’s Ethics and Medical Registration Board issued new NMC advertising guidelines for doctors, hospitals and medical institutions, effective immediately. For the first time, the rules explicitly treat AI-generated and AI-assisted content as advertising, ban AI-generated promotional campaigns for commercial interest, and prohibit synthetic patient testimonials.

Most coverage has focused on influencers, paid reviews and “No.1 doctor” claims. But the guidelines also reach the everyday digital tools clinics now depend on, including WhatsApp, online platforms and any AI system that touches patient information. This guide explains what changed and offers a practical checklist for clinics using AI.

What the NMC advertising guidelines actually say

The notice is titled Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners. According to Medical Dialogues’ detailed report of 7 October 2026, the notice is dated 06.10.2026, was issued by the EMRB, and is to be read with the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, and the NMC Act, 2019. The official notice is available on the NMC website.

The headline provisions, as reported across the coverage, include:

  • A broad definition of advertising. Digital, social media, sponsored, influencer-led, search-engine, platform-based, audio-visual, AI-generated and AI-assisted promotion are all covered, as summarised by Storyboard18 on 8 October 2026.
  • No unverifiable claims. “Guaranteed cures”, “100% success” and superiority claims such as “best” or “No.1” are barred unless objectively verifiable.
  • No inducements or referral payments. Commissions, referral fees and lead-generation payments tied to patient referrals are prohibited, as are discounts or free procedures that encourage unnecessary care. Factual disclosure of charges is allowed.
  • No fake reviews or manipulated reach. Buying or manipulating followers, ratings, reviews or search rankings is out.
  • Platforms are covered too. Healthcare platforms that host doctors must follow the norms, may not sell paid rankings, and must keep listings transparent.
  • Responsibility does not transfer. Publishing through an agency, influencer or intermediary does not absolve a doctor or institution of content they authorised or knowingly permitted.

Penalties are graded. A first violation brings a warning and mandatory ethics training; repeated violations can lead to removal from the medical register for one to three years, after a show-cause notice. Hospitals are dealt with under the Clinical Establishments Act or applicable state law.

Clinic manager and doctor reviewing the NMC advertising guidelines together in an Indian polyclinic office

The AI rules: what clinics using AI must know

The AI section is what makes these guidelines new. Medical Dialogues reported on 8 October 2026 that the rules set out four specific limits on AI-generated or AI-assisted content:

  1. No misleading AI content about diagnosis, treatment, clinical outcomes, qualifications, patient experiences or healthcare services.
  2. No synthetic patients. AI may not be used to create or alter a patient’s image, testimonial, voice or clinical outcome, or to fabricate an endorsement that appears to come from a real person.
  3. Disclosure. Where AI-generated or materially AI-altered content could matter to the audience’s understanding, it must be disclosed. Permitted AI promotional content must carry a source mark stating that it originated from AI.
  4. Privacy for AI inputs. Using patient information as input to an AI system must comply with privacy, confidentiality, data-protection and professional-ethics requirements.

On top of this, AI-generated promotional campaigns for commercial interest are prohibited outright. The News Mill noted that the NMC formally defines AI within the guidelines and that the covered channels include WhatsApp, Telegram and Facebook, as well as websites, blogs, podcasts and online healthcare platforms.

The fourth point deserves attention. It is not about marketing at all. It says that the moment patient information enters an AI tool, privacy and data-protection obligations apply. For clinics experimenting with general-purpose chatbots to draft notes, letters or social posts, that is a direct signal to check where the data goes.

Clinical communication versus promotion

A sensible reading of the NMC advertising guidelines separates two kinds of communication.

Clinical and operational communication is the information a patient needs to receive care: appointment reminders, follow-up instructions, prescriptions, lab-report explanations, diet plans. The guidelines expressly recognise that factual information has a place. Medical Dialogues reports that a hospital website directory listing doctors’ names, qualifications, specialties, registration details and availability serves a patient-information function and is distinct from paid advertising.

Promotional communication is anything with a promotional character: campaigns to attract new patients, testimonials, before-and-after content, offers and rankings. This is where the restrictions bite.

The risk for clinics is that the two blur on the same channel. A WhatsApp number used for follow-up reminders can easily drift into broadcast offers, “share your experience” requests or AI-written promotional messages. Keeping clinical messaging structured, tied to an actual visit and logged makes it much easier to show that it is care, not solicitation.

Doctor speaking directly with a patient during an in-person consultation in an Indian clinic

A practical NMC compliance checklist for AI-enabled clinics

Use this list with your practice manager and anyone who handles your digital channels:

  • Audit every AI tool you use. List each AI service that sees patient data, such as scribes, chatbots and image tools, and record where that data is processed and stored.
  • Stop using public chatbots on identifiable patient data unless you are satisfied the privacy and data-protection requirements are met.
  • Remove AI-generated promotional material created for commercial interest, and never use AI to produce patient images, voices or testimonials.
  • Label permitted AI content with a clear source mark where the guidelines require it.
  • Review your WhatsApp use. Keep it to visit-linked clinical communication; avoid broadcast offers, discounts and review requests.
  • Check agency and platform contracts. Because responsibility does not transfer, you need to know what is being published in your name.
  • Rewrite claims on your website and profiles so they are factual and verifiable: services, facilities, timings, qualifications and charges.
  • Document patient consent properly where any patient material is used. Medical Dialogues reports the guidelines require consent to be specific, informed, voluntary, documented and verifiable, and note that consent alone does not make a prohibited practice acceptable.

How the DPDP timeline adds pressure

The guidelines also point clinics to the IT Act, 2000, and the Digital Personal Data Protection Act, 2023, with its 2025 Rules, for the handling of digital personal data, according to Medical Dialogues. That timeline is moving. The dpdprules.org commencement tracker, last verified on 18 October 2026, lists the Consent Manager provisions for 13 November 2026 and the main obligations and rights for 13 May 2027. Both dates are computed from the Rules’ notification on 13 November 2025 and are marked as pending official confirmation, although the tracker notes a MeitY press release reporting 13 May 2027 as the full-enforcement date.

In practice, the NMC’s AI-privacy expectation and DPDP obligations converge on the same question: can your clinic show which systems hold patient data, who can access them, and what AI does with it? The InstaDataHelp blog has covered ABDM readiness and verified prescriptions earlier; these guidelines add a professional-conduct reason to get the same housekeeping done.

How InstaPraxis supports responsible AI use in clinics

InstaPraxis is a unified clinic OS built in India, for India. It is clinical and operational software, not a marketing tool, and no software can make a clinic’s advertising compliant on its behalf. What it can do is keep the AI and patient communication a clinic depends on inside one governed system:

  • AI as decision-support, not diagnosis. Vital Scan, BreathScan, DermaScan and ChestScan run inside the live consultation, and every output is AI decision-support for the treating clinician’s review. The four AI scans run inference on-device.
  • Role-aware agents with confirmation. The Doctor, Patient and Clinic Agents each only know what their user is allowed to know, use a curated tool catalogue, and ask for explicit confirmation before changing data.
  • Audit-logged by design. InstaPraxis is audit-logged and ABDM-ready, with ABHA/HPR/HFR alignment on the roadmap, which helps when you need to show who did what.
  • Visit-linked communication. Quick Rx for WhatsApp, QR-verified prescriptions, the plain-language lab-report AI and the AI diet generator are tied to actual consultations, which keeps patient messaging clinical.
  • Deployment control. Clinics can choose SaaS, a Single-Tenant VPS, or On-Prem / Air-Gapped deployment with bring-your-own LLM, so data location can match a clinic’s risk appetite.

The AI clinical scribe produces a bilingual Hindi and English SOAP note for the doctor to review, which keeps the clinician, not the software, responsible for the record.

Frequently Asked Questions

When were the NMC advertising guidelines issued?

The NMC’s Ethics and Medical Registration Board issued the Guidelines on Ethical Advertising and Public Communication on 6 October 2026, and they came into force with immediate effect.

Do the NMC advertising guidelines ban AI for doctors?

No. They do not ban AI in clinical practice. They prohibit AI-generated promotional campaigns for commercial interest, synthetic patient testimonials and misleading AI content, require disclosure of AI-generated content where relevant, and say patient information used as AI input must meet privacy and data-protection requirements.

Do the guidelines apply to WhatsApp messages from clinics?

Coverage of the guidelines lists WhatsApp among the channels covered where communication has a promotional character. Clinics should keep WhatsApp to visit-linked clinical communication and avoid offers, inducements or review requests.

How does InstaPraxis help clinics use AI responsibly?

InstaPraxis keeps AI scans as decision-support for the clinician’s review, runs scan inference on-device, uses role-aware agents that ask for confirmation before changing data, is audit-logged, and offers SaaS, single-tenant and on-prem deployment options.

Sources

The new NMC rules reward clinics that keep AI under clinical control and patient data inside governed systems. Explore InstaPraxis with a 30-day pilot, all features unlocked, or write to info@instadatahelp.com to see it in your clinic.

Share this article

Leave a comment

Your email address will not be published. Required fields are marked *

Keep reading

Related articles

Verified by MonsterInsights